Societal costs of untreated perinatal mood and anxiety disorders in Vermont

被引:1
|
作者
Platt, Isabel S. [1 ]
Pendl-Robinson, Emma L. [1 ]
Dehus, Eric [1 ]
O'Neil, Sasigant So [1 ]
Vohra, Divya [1 ]
Kenny, Michael [2 ]
Pentenrieder, Laura [2 ]
Zivin, Kara [1 ]
机构
[1] Mathematica, 1100 First St,NE,12th Floor, Washington, DC 20002 USA
[2] Vermont Dept Hlth, 108 Cherry St, Burlington, VT 05402 USA
关键词
Perinatal mental health; PMADs; Maternal health; Cost analysis; Health economics; SCALE FACTOR STRUCTURE; BONDING FAILURE; MATERNAL DEPRESSION; POSTPARTUM PERIOD; INFANT; OXYTOCIN; PREGNANCY; CORTISOL; ASSOCIATIONS; PREVALENCE;
D O I
10.1007/s00737-024-01429-1
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
PurposeTo estimate the societal costs of untreated perinatal mood and anxiety disorders (PMADs) in Vermont for the 2018-2020 average annual birth cohort from conception through five years postpartum.MethodsWe developed a cost analysis model to calculate the excess cases of outcomes attributed to PMADs in the state of Vermont. Then, we modeled the associated costs of each outcome incurred by birthing parents and their children, projected five years for birthing parents who do not achieve remission by the end of the first year postpartum.ResultsWe estimated that the total societal cost of untreated PMADs in Vermont could reach $48 million for an annual birth cohort from conception to five years postpartum, amounting to $35,910 in excess societal costs per birthing parent with an untreated PMAD and their child.ConclusionOur model provides evidence of the high costs of untreated PMADs for birthing parents and their children in Vermont. Our estimates for Vermont are slightly higher but comparable to national estimates, which are $35,500 per birthing parent-child pair, adjusted to 2021 US dollars. Investing in perinatal mental health prevention and treatment could improve health outcomes and reduce economic burden of PMADs on individuals, families, employers, and the state.
引用
收藏
页码:585 / 594
页数:10
相关论文
共 50 条
  • [1] Perinatal Mood and Anxiety Disorders
    Byrnes, Lorraine
    JNP- THE JOURNAL FOR NURSE PRACTITIONERS, 2018, 14 (07): : 507 - 513
  • [2] Perinatal Mood and Anxiety Disorders
    不详
    NURSING FOR WOMENS HEALTH, 2022, 26 (03) : e12 - e15
  • [3] Perinatal Mood and Anxiety Disorders
    不详
    JOGNN-JOURNAL OF OBSTETRIC GYNECOLOGIC AND NEONATAL NURSING, 2022, 51 (04): : E1 - E4
  • [4] Polypharmacy for perinatal mood and anxiety disorders
    Viguera, Adele C.
    LANCET PSYCHIATRY, 2024, 11 (08): : 575 - 577
  • [5] The hidden costs of untreated anxiety disorders
    Candilis, PJ
    Pollack, MH
    HARVARD REVIEW OF PSYCHIATRY, 1997, 5 (01) : 40 - 42
  • [6] Duration of untreated illness in anxiety and mood disorders
    Dell'Osso, B.
    Mundo, E.
    Albano, A.
    Buoli, M.
    Serati, M.
    Ciabatti, M.
    Altamura, A. C.
    EUROPEAN PSYCHIATRY, 2008, 23 : S369 - S369
  • [7] Duration of untreated illness in anxiety and mood disorders
    Altamura, A. C.
    Dell'Osso, B.
    Albano, A.
    Buoli, M.
    Serati, M.
    Ciabatti, M.
    Mundo, E.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2008, 11 : 201 - 202
  • [8] Financial Toll of Untreated Perinatal Mood and Anxiety Disorders Among 2017 Births in the United States
    Luca, Dara Lee
    Margiotta, Caroline
    Staatz, Colleen
    Garlow, Eleanor
    Christensen, Anna
    Zivin, Kara
    AMERICAN JOURNAL OF PUBLIC HEALTH, 2020, 110 (06) : 888 - 896
  • [9] The epidemiology of anxiety disorders:: Prevalence and societal costs
    Lépine, JP
    JOURNAL OF CLINICAL PSYCHIATRY, 2002, 63 : 4 - 8
  • [10] Treatment of perinatal mood and anxiety disorders: A review
    Misri, Shaila
    Kendrick, Kristin
    CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 2007, 52 (08): : 489 - 498